SW033291 is primarily used in research settings to study its role as a potent inhibitor of the 15-hydroxyprostaglandin dehydrogenase (15-PGDH) enzyme. By inhibiting this enzyme, it enhances the levels of prostaglandin E2 (PGE2), which plays a crucial role in tissue repair and regeneration. This makes it a promising candidate for investigating therapeutic applications in areas such as wound healing, tissue regeneration, and the treatment of diseases where PGE2 modulation is beneficial, such as inflammatory bowel disease and certain types of cancer. Additionally, it is utilized in preclinical studies to explore its potential in enhancing stem cell proliferation and improving outcomes in organ repair and transplantation.